Carbamic Acid

Carbamic Acid

SCHEMBL18320905

CC(C)(C)c1cc[nH]n1.NC(=O)O

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
MAPT P10636 2/20 0.34
KMT2A Q03164 2/20 0.34
GRN P28799 3/20 0.33
SORT1 Q99523 3/20 0.33
CDK8 P49336 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
AURKA O14965 1/20 0.33
CSF1R P07333 1/20 0.33
RET P07949 1/20 0.33
LTK P29376 1/20 0.33
CSNK1A1 P48729 1/20 0.33
CLK2 P49760 1/20 0.33
CDK5 Q00535 1/20 0.33
ACVR1 Q04771 1/20 0.33
CLK4 Q9HAZ1 1/20 0.33
KDM4E B2RXH2 1/20 0.33
TNF P01375 1/20 0.31
KLF5 Q13887 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL179489 0.85
SCHEMBL29798423 0.83 HPGD (0.37) HPGDTSHR
Ammonia Solution, Strong SCHEMBL22505596 0.83 HPGD (0.37) HPGDTSHR
SCHEMBL3419918 0.81 MAPT (0.42) MAPTKMT2ACDK8LTKMEN1
SCHEMBL5291126 0.79 CYP1A2 (0.35) HPGDMAPTKMT2ASMN1; SMN2KDM4E
SCHEMBL29168221 0.78
SCHEMBL20916432 0.78 HPGD (0.34) HPGDTSHR
SCHEMBL17183607 0.78 HPGD (0.34) HPGDTSHR
Pyridine SCHEMBL28480169 0.77 TSHR (0.39) HPGDTSHR
SCHEMBL3422617 0.76 MAPT (0.47) MAPTKMT2ASMN1; SMN2KDM4ECYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117529476-A Preparation of substituted 1, 2-diamino heterocyclic derivatives and their use as medicaments 亚飞络思制药公司 2024-02-06 CN disclosed
WO-2016202759-A1 CYTOTOXIC SUBSTITUTED 2-(1 H-PYRAZOL-1 -YL)-1,3-BENZOTHIAZOLE COMPOUNDS FOR THE TREATMENT OF CANCER BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-12-22 WO disclosed